Arrowhead Pharmaceuticals Inc (ARWR) stock forecast — our track record

Lyra published 4 ARWR stock forecasts starting February 15, 2026. Each prediction was published before the outcome was known, then closed and scored after the forecast window ended. All 4 calls used the same horizon, short term (0 to 3 months). The last closed window ended on May 24, 2026, so this track record covers forecasts made from February 15, 2026 through that completed period.

Overall, the predictions did well. The target was reached in 4 forecasts, with no misses and no partial results. The average success score was 93.8%. The average peak gain was 28.2%. Since every forecast was short term, the short-term average score was also 93.8%. That is the only horizon with closed ARWR calls here.

The best call was published on February 23, 2026. It predicted 20% growth, and the stock rose 29.1% at its peak. The target was reached after 59 days, and the call received a 100% score. The weakest call was published on February 18, 2026. It predicted 28% growth, and the stock rose 26.8% at its peak. It received a 75% score. Most of the record was clean, and even the weakest call was close to its stated target.